Följ
Jonah Larkins-Ford
Jonah Larkins-Ford
Sackler School of Graduate Biomedical Sciences
Verifierad e-postadress på tufts.edu
Titel
Citeras av
Citeras av
År
High-throughput screen for novel antimicrobials using a whole animal infection model
TI Moy, AL Conery, J Larkins-Ford, G Wu, R Mazitschek, G Casadei, ...
ACS chemical biology 4 (7), 527-533, 2009
2522009
Pseudomonas aeruginosa disrupts Caenorhabditis elegans iron homeostasis, causing a hypoxic response and death
NV Kirienko, DR Kirienko, J Larkins-Ford, C Wählby, G Ruvkun, ...
Cell host & microbe 13 (4), 406-416, 2013
2102013
OSM-11 facilitates LIN-12 Notch signaling during Caenorhabditis elegans vulval development
H Komatsu, MY Chao, J Larkins-Ford, ME Corkins, GA Somers, T Tucey, ...
PLoS biology 6 (8), e196, 2008
1672008
Sexual and social stimuli elicit rapid and contrasting genomic responses
ME Cummings, J Larkins-Ford, CRL Reilly, RY Wong, M Ramsey, ...
Proceedings of the Royal Society B: Biological Sciences 275 (1633), 393-402, 2008
1512008
Identification of antifungal compounds active against Candida albicans using an improved high-throughput Caenorhabditis elegans assay
I Okoli, JJ Coleman, E Tempakakis, WF An, E Holson, F Wagner, ...
PloS one 4 (9), e7025, 2009
1372009
C. elegans Notch signaling regulates adult chemosensory response and larval molting quiescence
K Singh, MY Chao, GA Somers, H Komatsu, ME Corkins, J Larkins-Ford, ...
Current Biology 21 (10), 825-834, 2011
1352011
Selective degradation of host RNA polymerase II transcripts by influenza A virus PA-X host shutoff protein
DA Khaperskyy, S Schmaling, J Larkins-Ford, C McCormick, MM Gaglia
PLoS pathogens 12 (2), e1005427, 2016
1332016
Efficient measurement and factorization of high-order drug interactions in Mycobacterium tuberculosis
M Cokol, N Kuru, E Bicak, J Larkins-Ford, BB Aldridge
Science advances 3 (10), e1701881, 2017
1202017
Whole animal automated platform for drug discovery against multi-drug resistant Staphylococcus aureus
R Rajamuthiah, BB Fuchs, E Jayamani, Y Kim, J Larkins-Ford, A Conery, ...
PloS one 9 (2), e89189, 2014
1072014
Stimulation of Host Immune Defenses by a Small Molecule Protects C. elegans from Bacterial Infection
R Pukkila-Worley, R Feinbaum, NV Kirienko, J Larkins-Ford, AL Conery, ...
PLoS genetics 8 (6), e1002733, 2012
942012
Stimulation of Host Immune Defenses by a Small Molecule Protects C. elegans from Bacterial Infection
R Pukkila-Worley, R Feinbaum, NV Kirienko, J Larkins-Ford, AL Conery, ...
PLoS genetics 8 (6), e1002733, 2012
942012
High-and low-throughput scoring of fat mass and body fat distribution in C. elegans
C Wählby, AL Conery, MA Bray, L Kamentsky, J Larkins-Ford, ...
Methods 68 (3), 492-499, 2014
712014
Insect-derived cecropins display activity against Acinetobacter baumannii in a whole-animal high-throughput Caenorhabditis elegans model
E Jayamani, R Rajamuthiah, J Larkins-Ford, BB Fuchs, AL Conery, ...
Antimicrobial agents and chemotherapy 59 (3), 1728-1737, 2015
592015
High‐Throughput Screening for Novel Anti‐Infectives Using a C. elegans Pathogenesis Model
AL Conery, J Larkins‐Ford, FM Ausubel, NV Kirienko
Current protocols in chemical biology 6 (1), 25-37, 2014
562014
A new antibiotic with potent activity targets MscL
I Iscla, R Wray, P Blount, J Larkins-Ford, AL Conery, FM Ausubel, S Ramu, ...
The Journal of antibiotics 68 (7), 453-462, 2015
552015
lin-12 Notch functions in the adult nervous system of C. elegans
MY Chao, J Larkins-Ford, TM Tucey, AC Hart
BMC neuroscience 6, 1-12, 2005
412005
Systematic measurement of combination-drug landscapes to predict in vivo treatment outcomes for tuberculosis
J Larkins-Ford, T Greenstein, N Van, YN Degefu, MC Olson, A Sokolov, ...
Cell systems 12 (11), 1046-1063. e7, 2021
362021
Berberine-INF55 (5-nitro-2-phenylindole) hybrid antimicrobials: effects of varying the relative orientation of the berberine and INF55 components
D Tomkiewicz, G Casadei, J Larkins-Ford, TI Moy, J Garner, JB Bremner, ...
Antimicrobial agents and chemotherapy 54 (8), 3219-3224, 2010
362010
Transcriptomic signatures predict regulators of drug synergy and clinical regimen efficacy against tuberculosis
S Ma, S Jaipalli, J Larkins-Ford, J Lohmiller, BB Aldridge, DR Sherman, ...
MBio 10 (6), 10.1128/mbio. 02627-19, 2019
352019
Morphological profiling of tubercle bacilli identifies drug pathways of action
TC Smith, KM Pullen, MC Olson, ME McNellis, I Richardson, S Hu, ...
Proceedings of the National Academy of Sciences 117 (31), 18744-18753, 2020
292020
Systemet kan inte utföra åtgärden just nu. Försök igen senare.
Artiklar 1–20